Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05791019
Other study ID # Paleolithic diet and T2DM
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2023
Est. completion date August 1, 2024

Study information

Verified date March 2023
Source Assiut University
Contact Nagy Nageh Abdo, Doctor
Phone 01069854486
Email nagynageh22@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Efficacy of paleolithic diet in control of blood glucose level in type 2 DM patients


Description:

Diabetes mellitus has become one of the most common progressive chronic diseases in the world, with 422 million people affected worldwide. Approximately 95% of people currently diagnosed with diabetes have type 2 diabetes mellitus (T2DM). The disease is characterized by chronic hyperglycemia, which can impair pancreatic beta cell function and increase insulin resistance, deteriorating the metabolic condition and causing microvascular complications in the retina, kidney or peripheral nerves . Thus, glycemic control is essential for diabetes management, in order to avoid complications in organs and systems, which are related with high morbidity and mortality rates. Among T2DM causes are genetic and epigenetic elements interacting within a societal framework. The genetic predisposition for T2DM takes into account the increased risk of an individual to develop T2DM when there are other family members affected. On the other hand, epigenetic elements are those influenced by environmental factors, i. e., they can be reversible, and therefore manipulated, in order to treat the disease. Regardless of the causes, the main targets of the treatment are focused on decreasing insulin resistance and improving beta cell function and decrease the inflammatory process through diet, exercise and antihyperglycemic agents. Based on this, given the high prevalence of the disease and the significant benefits of its management, it is of clinical importance to determine the proper amount and type of carbohydrates in patients' diet, as they both may influence the glycemic index of a meal. Besides, some foods' intake induce a marked rise followed by a more or less rapid fall in blood glucose, while others produce a smaller peak along with a more gradual decline in plasma glucose. Currently, it is recommended for T2DM patients an intake of 26-44% of total daily energy from carbohydrates, preferably from high-quality sources, such as vegetables, whole fruits and legumes , which are rich in fiber. Most fibers, which are unabsorbed carbohydrates, are insoluble and increase stool weight. In contrast, starches are carbohydrates found in vegetables that are mostly broken down to sugars by digestive enzymes. Resistant starch, also found in vegetables and whole fruits, escapes digestion, being fermented in the intestine as well as dietary fiber. Although the quantity and the quality of carbohydrates in the diet influence blood glucose levels , influencing insulin secretion and gastric emptying, the most beneficial type, the ideal amount of dietary carbohydrates and the underlying mechanisms involved remain a matter of debate. Thus, this study was designed to systematically review the effects of the type and amount of dietary carbohydrates in studies involving T2DM , in order to clarify these aspects for improving T2DM management.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date August 1, 2024
Est. primary completion date July 1, 2024
Accepts healthy volunteers
Gender All
Age group 20 Years to 45 Years
Eligibility Inclusion Criteria: - Newly diagnosed type 2 DM, age less than 45 years old Exclusion Criteria: - type 1 DM infection bariatric surgery not follow diet regimine before study at least 6 month not on medication for weight reduction

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Paleolithic diet effect on patients
Efficacy of paleolithic diet in control of blood level of glucose in type 2 DM patients

Locations

Country Name City State
Egypt Nagy Nageh Abdo Assiut

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Kleiner A, Cum B, Pisciotta L, Cincione IR, Cogorno L, Prigione A, Tramacere A, Vignati A, Carmisciano L, Sukkar SG. Safety and Efficacy of Eucaloric Very Low-Carb Diet (EVLCD) in Type 1 Diabetes: A One-Year Real-Life Retrospective Experience. Nutrients. 2022 Aug 5;14(15):3208. doi: 10.3390/nu14153208. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of paleolithic diet in control of blood glucose levels in type 2 DM patients Controlling of glucose levels in blood by using specific dietary system and notifying the number of participants who achieve good results Baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06079463 - The Effect of Progressive Relaxation Exercise on Anxiety and Quality of Life of Diabetic Patients N/A
Completed NCT01585792 - Double Blind Comparative Study of TAK-875 Phase 3
Recruiting NCT05681533 - Epicardial Adipose Tissue and Arterial Stiffness in People Living With Diabetes (METAB-CV-PWV)
Withdrawn NCT01972477 - DLBS1449 in Diabetic Patients With Low HDL Phase 2/Phase 3
Completed NCT03917940 - Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride N/A
Recruiting NCT06030544 - Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY) Phase 2